An observational, prospective cohort study to evaluate the safety and efficacy of Remsima in patients with Crohn's disease (CD) and Ulcerative Colitis (UC)

10/06/2015
15/02/2019
EU PAS number:
EUPAS9917
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

CT-P13 4 3 IBD registry protocol_EU-specific_Ver 2.1_Final_03Jun15 Synopsis for PASS_clean

English (31.03 KB - PDF) View document
Study results
Study report
Other information